Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.
Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.
Recruiting · NCT06264570 · Registry updated 2025-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, cardiovascular disorder, hereditary disease, hyperhomocysteinemia, inborn disorder of amino acid metabolism, inborn errors of metabolism, malabsorption syndrome, metabolic disease, nutritional deficiency disease, nutritional disorder, vitamin B deficiency, vitamin deficiency disorder | Recruiting | Not applicable | 2025-06-08 | NCT06264570 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Center of New Medical Technologies | 5 |
| S.LAB (SOLOWAYS) | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center of New Medical Technologies | Novosibirsk | Russia | 3 |